首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1110092

成人疫苗市場：按疫苗、疫苗類型、技術、地區 - 規模、份額、前景、機會分析，2022-2030

Adult Vaccines Market, by Vaccine, by Vaccine Type, by Technology, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年07月08日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

疫苗是提高免疫力以對抗某些疾病的生物製劑。疫苗由減毒、殺死或破碎的微生物、毒素或抗體製成的懸浮液組成，主要用於預防疾病的患者。疫苗通過刺激免疫系統攻擊它們來提供針對特定有害或致病因子的主動免疫。疫苗有助於保護患者免受流感和麻疹等嚴重和致命疾病的侵害。成人免疫接種：適用於 18 歲及以上的患者，包括使用許可用於醫療適應症的疫苗。常規接種疫苗是為了消除嬰兒和兒童的傳染病，但美國疾病控制和預防中心 (CDC) 2017 年將其稱為成人疫苗，建議成人也定期接種疫苗。根據 CDC 2015 年的數據，美國 2020 年健康人使命計劃中 30% 的患者選擇了帶狀皰疹疫苗，並報告說可以預防可預防的疾病。成人疫苗接種給 18 歲及以上的人。

市場動態

市場參與者越來越專注於開發針對最有可能像流行病一樣傳播的疾病的疫苗。例如，2017 年 2 月，總部位於印度的製藥公司 Cipla 與印度血清研究所合作，為該國的成年人推出了乙型肝炎疫苗。根據印度的普遍免疫計劃，該疾病在 2018 年長期影響該國超過 4000 萬人。此外，生物製藥公司 Dynavax Technologies Corporation 於 2018 年獲得美國食品藥品監督管理局 (U.S.FDA) 的批准，該疫苗適用於 18 歲及以上成人的兩劑乙型肝炎疫苗。

本研究的主要特點

本報告對全球成人疫苗市場進行了深入分析，提供了以 2021 年為基準年的預測期間（2022-2030 年）的市場規模和復合年增長率 (CAGR%) 的增長。
解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
該研究還提供了有關市場驅動因素、抑制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
基於公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數的全球成人疫苗市場主要參與者的概況。
本次調查涵蓋的主要公司包括葛蘭素史克公司、默克公司、賽諾菲巴斯德公司、輝瑞公司、CSL 有限公司、強生公司、印度血清研究所、Medimmune 和阿斯利康公司。
本報告中的見解將使營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球成人疫苗市場報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
用於分析全球成人疫苗市場的各種戰略矩陣將有助於利益相關者做出決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第2章市場展望

舉報內容
- 市場定義和範圍
執行摘要
- 市場快照：按疫苗分類
- 市場快照：按疫苗類型
- 市場概覽：按技術分類
- 市場概況：按地區劃分
連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

市場動態
- 驅動程序
- 限制因素
- 市場機會
主要亮點
市場趨勢
PEST 分析
政府和非政府舉措
流行病學

第 4 章全球成人疫苗市場 - COVID-19 影響分析

整體影響
政府舉措
COVID-19 對市場的影響

第 5 章全球成人疫苗市場，按疫苗，2017-2030 年

流感
破傷風、白喉、百日咳 (Td/Tdap)
水痘
人乳頭瘤病毒
帶狀皰疹
麻疹、腮腺炎、風疹 (MMR)
肺炎球菌
肝炎
其他

第 6 章按疫苗類型分列的成人疫苗全球市場（2017-2030 年

單價疫苗
多價疫苗

第 7 章全球成人疫苗市場：按技術，2017-2030 年

2022 年和 2030 年市場份額分析 (%)
2018-20230 年同比增長分析
細分趨勢

減毒活疫苗
- 2017-2030 年市場規模、預測、同比增長率
滅活□□病毒/細菌疫苗
- 2017-2030 年市場規模、預測和同比增長率
類毒素疫苗
- 市場規模及預測，2017 年至 2030 年的同比增長率
重組疫苗
- 市場規模及預測，2017-2030 年同比增長率
結合疫苗
- 2017-2030 年市場規模和預測，同比增長率

第 8 章按地區分列的成人疫苗全球市場，2017-2030 年

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海合會
以色列
其他中東地區
非洲
北非
中非
南非

第 9 章競爭格局

熱圖分析
市場份額分析
公司簡介
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Sanofi Pasteur
- Pfizer, Inc.
- CSL Limited
- Johnson & Johnson
- Serum Institute of India
- Medimmune
- AstraZeneca Plc.

第10章章節

調查手法介紹
關於出版社

簡介目錄

Product Code: CMI1091

Vaccines refer to the biological preparation that improves immunity to fight against a particular disease. Vaccines comprise suspensions formulated from weakened, killed or fragmented microorganisms, toxins or antibodies that are administered to a patient, with a primary intention to prevent a disease. Vaccines offer active immunity against specific harmful and disease causing agents by stimulating the immune system to attack the agent. Vaccines helps to protect individuals against serious and fatal diseases such as influenza and measles among others. Adult immunization that includes administration of licensed vaccine provided to patients aged 18 years and older, for medical indications. Vaccines are routinely administered to eliminate the infectious diseases among infants and children, however the Centers of Disease Control & Prevention (CDC), 2017, also recommends adults to periodically take up vaccination, referred to as adult vaccines. According to the CDC 2015, 30% of the patients from mission Healthy People program in the U.S. 2020 opted for shingles vaccine and were reported to be safe from preventable illness. Adult vaccines are given to age group to 18 year old and above.

Market Dynamics

Market players are increasingly focusing on creating vaccinations for illnesses having the highest risk of spreading like an epidemic. For instance, in February 2017, an India-based drug firm, Cipla, in collaboration with Serum Institute of India, introduced Hepatitis B vaccine for adults in the country. The disease affects chronically over 40 million people in 2018 in the country, as per India's Universal Immunization Program. Moreover, Dynavax Technologies Corporation, Biopharmaceutical Company received the United States Food and Drug Administration (U.S.FDA) approval in 2018, for its two-dosed Hepatitis-B vaccine indicated for adults aged 18 years and older.

Key features of the study:

This report provides an in-depth analysis of the global adult vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Detailed Segmentation:

Global Adult Vaccines Market, By Vaccines:
- Influenza
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Varicella
- Human Papillomavirus
- Zoster
- Measles, Mumps, Rubella (MMR)
- Pneumococcal
- Hepatitis
- Others
Global Adult Vaccines Market, By Vaccine Type:
- Monovalent
- Multivalent
Global Adult Vaccines Market, By Technology:
- Live Attenuated Vaccines
- Inactivated Viral/Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
Global Adult Vaccines Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- GlaxoSmithKline Plc *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
- Sanofi Pasteur
- Pfizer, Inc.
- CSL Limited
- Johnson & Johnson
- Serum Institute of India
- Medimmune
- AstraZeneca Plc.

"" marked represents similar segmentation in other categories in the respective section.*

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Key Highlights
Market Trends
PEST Analysis
Government & Non-Government Initiatives
Epidemiology

4. Global Adult Vaccines Market- COVID-19 Impact Analysis

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Adult Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Varicella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Human Papillomavirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Zoster
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Measles, Mumps, Rubella (MMR)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

6. Global Adult Vaccines Market, By Vaccine Type , 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Monovalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Multivalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Adult Vaccines Market, By Technology, 2017 - 2030, (US$ Million)

Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 20230
Segment Trends

Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Inactivated Viral/Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Adult Vaccines Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa